Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation. [electronic resource]
Producer: 20090331Description: 783-9 p. digitalISSN:- 1460-2377
- Animals
- Animals, Genetically Modified
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- CD8-Positive T-Lymphocytes -- drug effects
- Dendritic Cells -- drug effects
- G(M1) Ganglioside -- immunology
- Heparin-binding EGF-like Growth Factor
- Immunity, Cellular
- Immunotherapy
- Intercellular Signaling Peptides and Proteins -- genetics
- Interleukin-2 -- antagonists & inhibitors
- Killer Cells, Natural -- drug effects
- Lung Neoplasms -- immunology
- Melanoma, Experimental -- immunology
- Mice
- Neoplasm Metastasis
- Neoplasm Transplantation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.